About COPAN
COPAN is a company based in Murrieta (United States) founded in 1994. It operates as a Direct-to-Consumer (D2C) and Professional Services. COPAN offers products and services including FLOQSwabs, WASP, and UTM. COPAN operates in a competitive market with competitors including Quanterix, Biocare Medical, Merck, BioLife Solutions and Telesis Bio, among others.
- Latest Funding Round$10M (USD), Grant
May 2020
- Investors
Products & Services of COPAN
COPAN offers a comprehensive portfolio of products and services, including FLOQSwabs, WASP, and UTM.
Innovative flocked swabs are used for sample collection.
Automated system is designed for microbiology lab efficiency.
Universal transport medium is used for specimen preservation.
Apps and channels of COPAN
its YouTube channel COPANusa has 13.7K subscribers and 30 videos.
Videos from COPAN
The most watched videos on COPAN's YouTube channel, COPANusa (13.7K subscribers). Click a video to play it here.
More on COPANusa.
Funding Insights of COPAN
- Total Rounds 1
- Last Round Grant — $10M
- First Round $10M
(May 2020)
- Investors Count 1
All 1 funding rounds of COPAN with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2020 | $10M | Grant | – | – |
1 investors in total: 1 institutional.
Investors in COPAN
COPAN has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Apple.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Consumer electronics, computers, and software are designed and sold worldwide. | 1976 | apple.com | Cupertino, United States |
Investor details for COPAN
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of COPAN
13 people are tracked at COPAN (6 in leadership, 7 in team).
| Name | Role | Group |
|---|---|---|
Ginny Bell | National Corporate Account Director | Leadership |
Silvio Lignarolo | Chief Sales Officer (cso) | Leadership |
Christian Coogan | National Sales Director | Leadership |
Fabrizio Mazzocchi | Chief Executive Officer | Leadership |
Amanda Schmidt | Sr. Marketing Director | Leadership |
Angelo Messa | Chief Financial Officer | Leadership |
Matthew Reidy MBA, MLS(ASCP) | Senior Business Development Manager | Team |
Andrew Berens, MBA, MLS(ASCP), SM | Business Development Manager, Northeast | Team |
Zuly Gómez Pérez | LATAM Business & Marketing Manager | Team |
Luke Cohen | Senior Marketing Manager | Team |
Dan Adler | Business Development Manager | Team |
Anna Pascual | Office Manager/Customer Care Team | Team |
Marco Agliardi | LAS Manager, East Region: US & Canada / Corporate Accounts | Team |
Complete people profiles for COPAN
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of COPAN
2 dated milestones of COPAN across 26 years, from founding to its latest funding, stage changes and deals.
- Founded COPAN is founded.
- Funding First funding round of $10.0M.
Competitors of COPAN
COPAN operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Quanterix, Biocare Medical, Merck, BioLife Solutions and Telesis Bio, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| quanterix.com | 2007 | Cambridge, United States | $99.5M | 141 | Assay kits for ultra-sensitive biomarker detection are developed. | |
| biocare.net | 1997 | Concord, United States | $85M | 161 | Primary antibodies and instruments for immunohistochemistry are manufactured. | |
| merckgroup.com | 1668 | Darmstadt, Germany | – | 922 | Merck is engaged in science and technology solutions globally. | |
| biolifesolutions.com | 1987 | Bothell, United States | – | 685 | Tissue hypothermic storage and cryopreservation freeze media are developed. | |
| telesisbio.com | 2013 | San Diego, United States | $25M | – | Online platform offering life sciences reagents and kits | |
| bio-rad.com | 1952 | Hercules, United States | – | 10 | Portfolio of products and services for life science research and clinical diagnostic markets | |
| siemens-healthineers.com | 1847 | Erlangen, Germany | – | 66,000 | AI-based medical diagnostics are developed for healthcare applications. | |
| apbiocode.com | 2008 | Santa Fe Springs, United States | $20.29M | 66 | Assay kits and instruments for in vitro diagnostics are developed. |
Detailed competitors of COPAN
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of COPAN
The website of COPAN (copanusa.com) receives about 17.4K visits a month.
- Monthly visits17.4K
▼ 5.4% vs previous month
Websites whose visitors overlap most with COPAN. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| hardydiagnostics.com | 100% | – | #583,854 | View details | |
| anaerobesystems.com | 90% | 5.2K | #3,699,045 | View details | |
liofilchem.net | liofilchem.net | 90% | – | #2,064,707 | – |
bact.wisc.edu | bact.wisc.edu | 89% | – | – | – |
textbookofbacteriology.net | textbookofbacteriology.net | 89% | – | – | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 23 similar websites and full traffic analytics for COPAN
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 23 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Copan
Complete news archive for COPAN
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to COPAN
10 companies that operate in the same segment as COPAN (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about COPAN
COPAN was founded in 1994 and raised its 1st funding round 26 years after it was founded.
COPAN is headquartered in Murrieta, United States. It is registered at Murrieta, California, United States.
Specimen collection and laboratory automation solutions are offered by COPAN. The company specializes in pre-analytics, focusing on sample collection, transport, and preservation devices. Sectors served include healthcare, forensics, and food safety. Advanced automation and AI technologies are integrated to enhance laboratory efficiency. Products like flocked swabs and transport media are developed to support medical and diagnostic communities. Collaborative innovation is emphasized in product development since the companys founding in 1979.
COPAN's top competitors include Biocare Medical, Merck and Siemens Healthineers.
COPAN offers FLOQSwabs, WASP, and UTM.
COPAN has 1 investor. Key investors include Apple.
COPAN operates through Copan Diagnostics Inc..